Leidos · 7 hours ago
Technical SIGINT SME (TechSIGINT)
Leidos is an industry and technology leader serving government and commercial customers. They are seeking a SIGINT Subject Matter Expert (SME) to drive Air Force and NSA Technical SIGINT policies and enhance capabilities within the ISR mission.
ComputerGovernmentInformation ServicesInformation TechnologyNational SecuritySoftware
Responsibilities
Be the essential bridge between the NSA and the Air Force for TechSIGINT revitalization, championing mission-critical needs and delivering enhanced capabilities
Provide strategic guidance on Air Force TechSIGINT and TCPED policies, strategies, and standards
Lead the way in operations management, crafting innovative plans and initiatives to strengthen the Air Force enterprise
Collaborate with 16 AF and its ISR Wings to sustain a high-performing operational environment, with a focus on compliance and quality assurance
Advocate for operational policies, influencing high-level decision-making alongside key leaders
Represent 16 AF with diverse organizations, fostering meaningful connections across DoD directorates, intelligence agencies, academia, and industry
Qualification
Required
Bachelor's Degree (with 10+ years of experience) or Master's Degree (with 8+ years of experience). Additional related experience, certifications and training may substitute for a degree
Current TS/SCI with Polygraph
Graduated from a DoD or National Intelligence Agency SIGINT school
Solid background in Tactical Processing, Exploitation, and Dissemination (PED)
Expertise in ISR platforms and direct collaboration with national and strategic intelligence missions
Strong familiarity with the Joint Command and DoD structure
Preferred
In-depth understanding of TechSIGINT policy and advanced-level SIGINT training
Previous work in an Air Operations Center (AOC) environment
Knowledge of national and airborne collection programs
Benefits
Health and Wellness programs
Income Protection
Paid Leave
Retirement
Company
Leidos
Leidos is a Fortune 500® innovation company rapidly addressing the world’s most vexing challenges in national security and health.
Funding
Current Stage
Public CompanyTotal Funding
unknown2025-02-20Post Ipo Debt
2013-09-17IPO
Leadership Team
Recent News
MarketScreener
2025-12-16
2025-12-16
Company data provided by crunchbase